University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
NORTH CAROLINA, April 2
VIRTUAL, September 30
Millie D. Long, MD, MPH, FACG, earned her Doctor of Medicine degree at the University of Virginia. She completed a residency and chief residency in internal medicine at the University of Alabama at Birmingham. She then completed a gastroenterology fellowship at the University of North Carolina at Chapel Hill. While at University of North Carolina, she also completed a fellowship in preventive medicine, advanced training in inflammatory bowel diseases, and a Master's of Public Health in epidemiology. She is board certified in internal medicine, preventive medicine and gastroenterology. She is currently an Associate Professor of Medicine in the Department of Medicine. She is the Gastroenterology and Hepatology Fellowship Program Director at UNC. Dr. Long's interests include research on prevention of complications of inflammatory bowel disease, women's health, and clinical outcomes research. Dr. Long has contributed numerous peer-reviewed publications, book chapters, and review articles to the medical literature. She has served as Associate Editor for IBD for The American Journal of Gastroenterology, and as an invited reviewer for journals such as Inflammatory Bowel Diseases, Gastroenterology, Clinical Gastroenterology and Hepatology, and Alimentary Pharmacology and Therapeutics. Dr. Long is a fellow of the ACG member and serves on the ACG Practice Parameters Committee as a GRADE reviewer and is chair of the ACG Research Committee. She is also a member of the AGA where she serves on the Education and Training Committee, and the Crohn's and Colitis Foundation, where she co-chairs the Clinical Research Alliance.
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
VIRTUAL, March 5
Corey A. Siegel, MD, MS, is the Section Chief of Gastroenterology and Hepatology and the Co-Director of the Inflammatory Bowel Disease (IBD) Center at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. He is the Constantine and Joyce Hampers Professor of Medicine and a Professor at The Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth. Dr. Siegel received his medical degree from Tufts University School of Medicine in Boston, Massachusetts in 1998. He completed his residency in internal medicine at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. Dr. Siegel served as chief medical resident at Dartmouth, where he also completed a fellowship in gastroenterology. From 2004-2005, he completed a fellowship in Inflammatory Bowel Disease at Massachusetts General Hospital in Boston, Massachusetts. Dr. Siegel’s research interests include understanding risk/benefit tradeoffs in IBD, developing models to predict outcomes in Crohn’s disease, creating tools to facilitate shared decision making, expanding telemedicine services to patients with IBD living in rural locations, and improving the quality of care delivered to patients with IBD. He has been funded by the NIH, AHRQ, the Crohn’s and Colitis Foundation, and the Leona M. and Harry B. Helmsley Charitable Trust for this work. Dr. Siegel is the founder of the BRIDGe group, an international research collaborative of IBD investigators. Dr. Siegel was inducted into the International Organization for the Study of IBD (IOIBD) in 2013. He lives in Hanover, New Hampshire with his wife and three boys.
University of Maryland School of Medicine
NORTH CAROLINA, April 2
Raymond K. Cross, Jr., MD, MS, FACG, is a Professor of Medicine, Division of Gastroenterology and Hepatology, at the University of Maryland, Baltimore. He is also Director of the Inflammatory Bowel Disease Program at the University of Maryland School of Medicine and is Co-Director of the Digestive Health Center at the University of Maryland Medical Center. Dr. Cross received his undergraduate degree from Washington and Jefferson College and his medical degree from the University of Pittsburgh School of Medicine. He completed his postgraduate training in Internal Medicine and Gastroenterology at the University of Maryland and Baltimore VA Medical Center. In addition, Dr. Cross obtained a Master of Science degree in Clinical Research at the University of Maryland School of Medicine. Dr. Cross has authored over 100 journal articles, reviews, and book chapters. His research interests include application of telemedicine in the care of patients with IBD, disparities, outcomes research and clinical trials. He is Co-Chair of the Clinical Research Alliance, past Chair of the Clinical Grants Review Committee and Patient Education Committee, and was selected as vanguard site investigator for IBD Plexus for the Crohn’s and Colitis Foundation.
Los Angeles, California
VIRTUAL, April 30
Gil Y. Melmed, MD, MS, is the Co-Director of the Inflammatory Bowel Disease Center at Cedars-Sinai Medical Center in Los Angeles, California. He earned his medical degree from Albert Einstein College of Medicine in the Bronx, New York, and master of science in clinical research from UCLA School of Medicine, Los Angeles. Dr. Melmed completed his gastroenterology fellowship at the University of California, Los Angeles.
He has authored or coauthored more than 130 articles in peer-reviewed journals and several book chapters. Dr. Melmed is an Associate Editor of the American Journal of Gastroenterology, an ad hoc reviewer for several journals, and previously a clinical research editor for Inflammatory Bowel Disease. His research interests include clinical outcomes and quality of care in IBD. He has given more than 100 invited lectures and presentations nationally and internationally. He is a committee member of several professional organizations, including the American College of Gastroenterology and the Crohn’s and Colitis Foundation, where he serves as co-chair of the IBD Quality of Care committee. He has led or participated in the development of quality measures for IBD with the American Gastroenterology Association, the Crohn’s and Colitis Foundation, and the Canadian Crohn’s and Colitis organizations.
New York, New York
BOSTON, June 11
Marla C. Dubinsky received a medical degree from Queen’s University in Canada and completed her clinical pediatric gastroenterology training at Sainte-Justine Hospital, University of Montreal in Quebec, Canada. Currently, Dr. Dubinsky is Chief of Pediatric Gastroenterology, Hepatology, and Nutrition, Co-Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, and Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai Hospital Medical Center in New York.
Board-certified in pediatric gastroenterology, Dr. Dubinsky holds positions of prominence with several advisory bodies, including President of We Care in IBD. She is a member of several professional societies, including the American Gastroenterology Association, the American College of Gastroenterology, and the American Academy of Pediatrics.
Cleveland Clinic Lerner College of Medicine
CHICAGO, July 23
Miguel Regueiro earned his bachelor’s degree at the University of Pennsylvania, his medical degree at Drexel (Hahnemann) University and completed his internal medicine internship, residency, and clinical and research fellowship training in gastroenterology at Harvard Medical School’s Beth Israel Hospital. Dr. Regueiro was Professor of Medicine and Clinical and Translational Science at the University of Pittsburgh School of Medicine from 2000 to 2018. There he served as the IBD Clinical Medical Director, Senior Medical Lead of Specialty Medical Homes, was Professor with Tenure, and honored as the UPMC Endowed Chair for Patient Centered Care in Inflammatory Bowel Diseases. Dr. Regueiro is currently the Chair of the Department of Gastroenterology and Hepatology and Vice Chair of the Digestive Disease and Surgery Institute at Cleveland Clinic in Ohio. He serves as Medical Co-Chair of Digestive Disease and Surgical Institute Research Governance committee and is Professor of Medicine at the Lerner College of Medicine, Cleveland Clinic. Dr. Regueiro’s main clinical and research interest is Inflammatory Bowel Diseases with a focus on the natural course of these diseases and postoperative prevention of Crohn’s disease. Recently, he has been involved in transformative medicine initiatives and developing new models of healthcare, including the first-of-its kind specialty medical home for IBD. Dr. Regueiro is investigating alternative models of care in population-based health that integrates patients, payers, providers, pharmaceutical industry, and other facets of healthcare delivery around these novel programs.
Houston Methodist - Weill Cornell
VIRTUAL, August 27
Bincy P. Abraham, MD, MS, is an associate professor of clinical medicine in the Academic Division of Gastroenterology and Hepatology at Houston Methodist – Weill Cornell in Houston, Texas.
Dr. Abraham earned her undergraduate degree in bioengineering at Texas A&M University in College Station, and then received her medical degree from the University of Texas Medical Branch (UTMB) in Galveston. She completed her internal medicine internship and residency, as well as a gastroenterology fellowship at UTMB, where she also earned a master’s in clinical investigation and received specialized training in inflammatory bowel disease (IBD). During her training, she completed a National Visiting Fellow IBD Rotation Program through the Crohn’s and Colitis Foundation of America at Cedars-Sinai Medical Center in Los Angeles, California. She is board-certified in Internal medicine and Gastroenterology. Dr. Abraham is a member of the American Gastroenterological Association, American College of Gastroenterology, Crohn’s and Colitis Foundation, American Society of Gastrointestinal Endoscopy, and chair of the South Texas Chapter of the Crohn’s and Colitis Foundation Medical Advisory Committee.